Medical Devices Investors & VC Firms

1641 firms in this list, with a median first check of $500K. 343 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
TU TusStar	88🔒	Beijing	CN	Pre-Seed–Series A	—	+ Add to CRM
CL Claremont Creek Ventures NGRHBWGO5 people	88🔒	Oakland	US	Seed–Late Stage	$500K – $3M	+ Add to CRM
RV RV Invest GmbH AZAACBLZ8 people	88🔒	Ravensburg	DE	Seed–Series A	—	+ Add to CRM
SI Sirius Venture Partners GmbH FVMBASJS8 people	88🔒	Wiesbaden	DE	Seed–Growth	$540K – $5.4M	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLSV11 people	88🔒	Contern	LU	Series B–Late Stage	$10.8M	+ Add to CRM
WA Waarde Capital BPAHJLAS5 people	88🔒	Capellen	LU	Seed–Growth	$15M	+ Add to CRM
WI Wilco AAARCTOH5 people · Follows rounds	88🔒	Paris	FR	Pre-Seed–Seed	$55K – $108K	+ Add to CRM
MP MPG Fund SGTG2 people	88🔒	—		Pre-Seed–Seed	—	+ Add to CRM
OO Oost NL JBSH2 people	88🔒	Apeldoorn	NL	Seed–Late Stage	$108K – $5.4M	+ Add to CRM
ZÜ Zühlke Ventures PGSW2 people · Follows rounds	88🔒	Zurich	CH	Pre-Seed–Series A	$165K – $275K	+ Add to CRM
MO Mohr Davidow Ventures BSESKFBE7 people	88🔒	San Mateo	US	Seed–Late Stage	$200K – $4M	+ Add to CRM
PO Polytechnique Ventures DLCTMCGD4 people · Leads rounds	88🔒	Paris	FR	Pre-Seed–Series A	—	+ Add to CRM
SE Seido Capital OBTRPEAL7 people · Leads rounds	88🔒	Brussels	BE	Pre-Seed–Series B	$270K – $2.7M	+ Add to CRM
SP Split Rock Partners JSMGSZDS4 people · Leads rounds	88🔒	Eden Prairie	US	Seed–Growth	$2M – $40M	+ Add to CRM
TO Torrey Pines Investment NSRMCRER7 people · Leads rounds	88🔒	San Diego	US	Seed–Series A	—	+ Add to CRM
UN Unfold Ventures JSAJACMS7 people	88🔒	Wrocław	PL	Pre-Seed–Late Stage	$110K – $1.1M	+ Add to CRM
CR Crescent Capital MMAWPGRM6 people	88🔒	Belfast	GB	Seed–Series A	$571.5K – $1.5M	+ Add to CRM
ET ETCapital MRJGDG3 people · Follows rounds	88🔒	Cambridge	GB	Seed–Series A	$100K – $952.5K	+ Add to CRM
IN Intelligence Ventures DNLLJBMY6 people	88🔒	—		Pre-Seed–Seed	$50K	+ Add to CRM
MI Militia Hill Ventures JHJLBEY9 people	88🔒	Philadelphia	US	Seed–Series A	—	+ Add to CRM
NO Novalis LifeSciences MDDLPMCG9 people	88🔒	Portsmouth	US	Seed–Late Stage	—	+ Add to CRM
HO Hourglass Venture Partners RRSELGS8 people	88🔒	San Francisco	US	—	—	+ Add to CRM
LE Leading Edge Ventures MBDPJDRB5 people	88🔒	Newark	US	Seed–Series A	$50K – $750K	+ Add to CRM
SU Sugati Ventures RDEGMCEH8 people · Leads rounds	88🔒	San Ramon	US	Seed–Series A	—	+ Add to CRM

TusStar

BeijingPre-Seed–Series A

Claremont Creek Ventures

OaklandSeed–Late Stage$500K – $3M

NGRHBWGO5 people

RV Invest GmbH

RavensburgSeed–Series A

AZAACBLZ8 people

Sirius Venture Partners GmbH

WiesbadenSeed–Growth$540K – $5.4M

FVMBASJS8 people

Vesalius Biocapital III Partners SàRL

ConternSeries B–Late Stage$10.8M

CSGGMLSV11 people

Waarde Capital

CapellenSeed–Growth$15M

BPAHJLAS5 people

Wilco

ParisPre-Seed–Seed$55K – $108K

AAARCTOH5 people

MPG Fund

Pre-Seed–Seed

SGTG2 people

Oost NL

ApeldoornSeed–Late Stage$108K – $5.4M

JBSH2 people

Zühlke Ventures

ZurichPre-Seed–Series A$165K – $275K

PGSW2 people

Mohr Davidow Ventures

San MateoSeed–Late Stage$200K – $4M

BSESKFBE7 people

Polytechnique Ventures

ParisPre-Seed–Series A

DLCTMCGD4 people

Seido Capital

BrusselsPre-Seed–Series B$270K – $2.7M

OBTRPEAL7 people

Split Rock Partners

Eden PrairieSeed–Growth$2M – $40M

JSMGSZDS4 people

Torrey Pines Investment

San DiegoSeed–Series A

NSRMCRER7 people

Unfold Ventures

WrocławPre-Seed–Late Stage$110K – $1.1M

JSAJACMS7 people

Crescent Capital

BelfastSeed–Series A$571.5K – $1.5M

MMAWPGRM6 people

ETCapital

CambridgeSeed–Series A$100K – $952.5K

MRJGDG3 people

Intelligence Ventures

Pre-Seed–Seed$50K

DNLLJBMY6 people

Militia Hill Ventures

PhiladelphiaSeed–Series A

JHJLBEY9 people

Novalis LifeSciences

PortsmouthSeed–Late Stage

MDDLPMCG9 people

Hourglass Venture Partners

San Francisco

RRSELGS8 people

Leading Edge Ventures

NewarkSeed–Series A$50K – $750K

MBDPJDRB5 people

Sugati Ventures

San RamonSeed–Series A

RDEGMCEH8 people

Data sourced from public filings and firms' own websites — see our methodology.